TCF3 and acute myeloid leukemia: DNA breakpoint junctions in both KMT2A-rearranged and TCF3-rearranged BCP-ALL/AML pairs were Sanger-sequenced using patient-specific primers (Table S3) and were shown to be identical (Figure 4).